u 101958 has been researched along with 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin in 1 studies
*2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin: potent, specific D2 dopamine receptor agonist; RN given refers to parent cpd [MeSH]
*2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin: potent, specific D2 dopamine receptor agonist; RN given refers to parent cpd [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, SF; Jackson, MB; Wilke, RA | 1 |
1 other study(ies) available for u 101958 and 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin
| Article | Year |
|---|---|
Dopamine D4 receptor mediated inhibition of potassium current in neurohypophysial nerve terminals.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminopyridines; Animals; Dopamine Agonists; Dopamine Antagonists; Electric Conductivity; Female; Kinetics; Male; Membrane Potentials; Nerve Endings; Patch-Clamp Techniques; Phenethylamines; Piperidines; Pituitary Gland, Posterior; Potassium; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides | 1998 |